• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

工程抗生素抗癌：优化新生霉素骨架产生抗增殖剂。

Engineering an antibiotic to fight cancer: optimization of the novobiocin scaffold to produce anti-proliferative agents.

机构信息

Department of Medicinal Chemistry, The University of Kansas, Lawrence, KS 66045-7563, USA.

出版信息

J Med Chem. 2011 Jun 9;54(11):3839-53. doi: 10.1021/jm200148p. Epub 2011 May 9.

DOI:10.1021/jm200148p
PMID:21553822
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3164572/
Abstract

Development of the DNA gyrase inhibitor, novobiocin, into a selective Hsp90 inhibitor was accomplished through structural modifications to the amide side chain, coumarin ring, and sugar moiety. These species exhibit ∼700-fold improved anti-proliferative activity versus the natural product as evaluated by cellular efficacies against breast, colon, prostate, lung, and other cancer cell lines. Utilization of structure-activity relationships established for three novobiocin synthons produced optimized scaffolds, which manifest midnanomolar activity against a panel of cancer cell lines and serve as lead compounds that manifest their activities through Hsp90 inhibition.

摘要

通过对酰胺侧链、香豆素环和糖部分的结构修饰，将 DNA 拓扑异构酶抑制剂新生霉素开发成选择性 Hsp90 抑制剂。这些化合物在细胞效价方面对乳腺癌、结肠癌、前列腺癌、肺癌和其他癌细胞系的增殖活性比天然产物提高了约 700 倍。利用为三种新生霉素合成子建立的构效关系，产生了优化的支架，这些支架对一系列癌细胞系表现出中纳摩尔的活性，并作为先导化合物，通过 Hsp90 抑制发挥其活性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/550d/3164572/127f65210fb5/nihms295690f19.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/550d/3164572/d38bee641eeb/nihms295690f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/550d/3164572/9f0f5001582c/nihms295690f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/550d/3164572/0649216af361/nihms295690f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/550d/3164572/f9d6bc433785/nihms295690f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/550d/3164572/2f447dcf9376/nihms295690f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/550d/3164572/028eba770b04/nihms295690f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/550d/3164572/13dd9ae5aca4/nihms295690f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/550d/3164572/b5e2212baf75/nihms295690f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/550d/3164572/ecf04a696f12/nihms295690f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/550d/3164572/9c7a743bd2f8/nihms295690f10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/550d/3164572/debfa80c9d8c/nihms295690f11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/550d/3164572/12dac324d30b/nihms295690f12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/550d/3164572/9306a97ac245/nihms295690f13.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/550d/3164572/4ebc6d93651b/nihms295690f14.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/550d/3164572/c58db7258f80/nihms295690f15.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/550d/3164572/9bb92b518897/nihms295690f16.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/550d/3164572/6d8358188c36/nihms295690f17.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/550d/3164572/46b51aae93c7/nihms295690f18.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/550d/3164572/127f65210fb5/nihms295690f19.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/550d/3164572/d38bee641eeb/nihms295690f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/550d/3164572/9f0f5001582c/nihms295690f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/550d/3164572/0649216af361/nihms295690f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/550d/3164572/f9d6bc433785/nihms295690f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/550d/3164572/2f447dcf9376/nihms295690f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/550d/3164572/028eba770b04/nihms295690f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/550d/3164572/13dd9ae5aca4/nihms295690f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/550d/3164572/b5e2212baf75/nihms295690f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/550d/3164572/ecf04a696f12/nihms295690f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/550d/3164572/9c7a743bd2f8/nihms295690f10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/550d/3164572/debfa80c9d8c/nihms295690f11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/550d/3164572/12dac324d30b/nihms295690f12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/550d/3164572/9306a97ac245/nihms295690f13.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/550d/3164572/4ebc6d93651b/nihms295690f14.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/550d/3164572/c58db7258f80/nihms295690f15.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/550d/3164572/9bb92b518897/nihms295690f16.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/550d/3164572/6d8358188c36/nihms295690f17.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/550d/3164572/46b51aae93c7/nihms295690f18.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/550d/3164572/127f65210fb5/nihms295690f19.jpg

相似文献

1
Engineering an antibiotic to fight cancer: optimization of the novobiocin scaffold to produce anti-proliferative agents.工程抗生素抗癌：优化新生霉素骨架产生抗增殖剂。
J Med Chem. 2011 Jun 9;54(11):3839-53. doi: 10.1021/jm200148p. Epub 2011 May 9.
2
Synthesis and Biological Evaluation of Novobiocin Core Analogues as Hsp90 Inhibitors.作为热休克蛋白90抑制剂的新生霉素核心类似物的合成与生物学评价
Chemistry. 2016 May 10;22(20):6921-31. doi: 10.1002/chem.201504955. Epub 2016 Apr 1.
3
Synthesis and biological evaluation of coumarin replacements of novobiocin as Hsp90 inhibitors.作为热休克蛋白90（Hsp90）抑制剂的新生霉素香豆素替代物的合成及生物学评价
Bioorg Med Chem. 2014 Feb 15;22(4):1441-9. doi: 10.1016/j.bmc.2013.12.056. Epub 2014 Jan 3.
4
Development of novobiocin analogues that manifest anti-proliferative activity against several cancer cell lines.表现出对多种癌细胞系具有抗增殖活性的新生霉素类似物的开发。
J Org Chem. 2008 Mar 21;73(6):2130-7. doi: 10.1021/jo702191a. Epub 2008 Feb 23.
5
Click chemistry to probe Hsp90: Synthesis and evaluation of a series of triazole-containing novobiocin analogues.点击化学法探测 Hsp90：一系列含三唑的诺氟沙星类似物的合成与评价。
Bioorg Med Chem Lett. 2010 Jul 1;20(13):3957-60. doi: 10.1016/j.bmcl.2010.04.140. Epub 2010 May 6.
6
Novobiocin Analogues That Inhibit the MAPK Pathway.抑制丝裂原活化蛋白激酶（MAPK）信号通路的新生霉素类似物
J Med Chem. 2016 Feb 11;59(3):925-33. doi: 10.1021/acs.jmedchem.5b01354. Epub 2016 Jan 27.
7
Novobiocin Analogs as Potential Anticancer Agents.新霉素类似物作为潜在的抗癌剂。
Mini Rev Med Chem. 2017;17(9):728-733. doi: 10.2174/1389557516666161223155525.
8
The synthesis and evaluation of flavone and isoflavone chimeras of novobiocin and derrubone.新型诺氟沙星和去甲二氢愈创木酸黄酮和异黄酮嵌合体的合成与评价。
Bioorg Med Chem. 2010 Jan 1;18(1):249-66. doi: 10.1016/j.bmc.2009.10.061. Epub 2009 Oct 31.
9
The design, synthesis, and evaluation of coumarin ring derivatives of the novobiocin scaffold that exhibit antiproliferative activity.对新霉素支架的香豆素环衍生物进行设计、合成及评估，这些衍生物具有抗增殖活性。
J Org Chem. 2008 Nov 21;73(22):8901-20. doi: 10.1021/jo801312r. Epub 2008 Oct 22.
10
Development of Phenyl Cyclohexylcarboxamides as a Novel Class of Hsp90 C-terminal Inhibitors.苯基环己基甲酰胺作为新型Hsp90 C端抑制剂的开发
Chemistry. 2017 Nov 21;23(65):16574-16585. doi: 10.1002/chem.201703206. Epub 2017 Nov 3.

引用本文的文献

1
Coumarin as an Elite Scaffold in Anti-Breast Cancer Drug Development: Design Strategies, Mechanistic Insights, and Structure-Activity Relationships.香豆素作为抗乳腺癌药物研发中的优良骨架：设计策略、作用机制及构效关系
Biomedicines. 2024 May 27;12(6):1192. doi: 10.3390/biomedicines12061192.
2
A silicon-containing aryl/penta-1,4-dien-3-one/amine hybrid exhibits antiproliferative effects on breast cancer cells by targeting the HSP90 C-terminus without inducing heat-shock response.一种含硅芳基/戊-1,4-二烯-3-酮/胺杂化物通过靶向热休克蛋白90（HSP90）的C末端对乳腺癌细胞发挥抗增殖作用，且不会诱导热休克反应。
RSC Med Chem. 2023 Oct 23;14(12):2625-2639. doi: 10.1039/d3md00431g. eCollection 2023 Dec 13.
3

本文引用的文献

1
Synthesis and Evaluation of Noviose Replacements on Novobiocin that Manifest Anti-proliferative Activity.新生霉素替代物的合成及其对具有抗增殖活性的新生霉素的评估。
ACS Med Chem Lett. 2010 Jul 13;1(7):311-315. doi: 10.1021/ml100070r.
2
To fold or not to fold: modulation and consequences of Hsp90 inhibition.折叠还是不折叠：Hsp90 抑制的调节和后果。
Future Med Chem. 2009 May;1(2):267-83. doi: 10.4155/fmc.09.17.
3
Alternate strategies of Hsp90 modulation for the treatment of cancer and other diseases.Hsp90 调节的替代策略用于癌症和其他疾病的治疗。
Synthesis and Evaluation of Small Molecule Disruptors of the Aha1/Hsp90 Complex for the Reduction of Tau Aggregation.
用于减少 Tau 蛋白聚集的 Aha1/Hsp90 复合物小分子干扰剂的合成与评估
ACS Med Chem Lett. 2022 Apr 15;13(5):827-832. doi: 10.1021/acsmedchemlett.2c00064. eCollection 2022 May 12.
4
An efficient, mild and metal free l-proline catalyzed construction of fused pyrimidines under microwave conditions in water.在微波条件下于水中高效、温和且无金属的L-脯氨酸催化构建稠合嘧啶。
RSC Adv. 2019 Feb 4;9(7):3755-3763. doi: 10.1039/c8ra07517d. eCollection 2019 Jan 25.
5
The quest for supernatural products: the impact of total synthesis in complex natural products medicinal chemistry.对超自然产物的追求：全合成对复杂天然产物药物化学的影响。
Nat Prod Rep. 2020 Nov 1;37(11):1511-1531. doi: 10.1039/d0np00060d. Epub 2020 Nov 10.
6
A Significant Question in Cancer Risk and Therapy: Are Antibiotics Positive or Negative Effectors? Current Answers and Possible Alternatives.癌症风险与治疗中的一个重要问题：抗生素是积极因素还是消极因素？当前的答案及可能的替代方案。
Antibiotics (Basel). 2020 Sep 6;9(9):580. doi: 10.3390/antibiotics9090580.
7
Dynamically Shaping Chaperones. Allosteric Modulators of HSP90 Family as Regulatory Tools of Cell Metabolism in Neoplastic Progression.动态塑造伴侣蛋白。HSP90家族的变构调节剂作为肿瘤进展中细胞代谢的调控工具。
Front Oncol. 2020 Jul 16;10:1177. doi: 10.3389/fonc.2020.01177. eCollection 2020.
8
Heat shock protein 90 inhibitors block the antinociceptive effects of opioids in mouse chemotherapy-induced neuropathy and cancer bone pain models.热休克蛋白 90 抑制剂阻断阿片类药物在小鼠化疗诱导的神经病变和癌性骨痛模型中的抗伤害作用。
Pain. 2020 Aug;161(8):1798-1807. doi: 10.1097/j.pain.0000000000001886. Epub 2020 Apr 10.
9
Investigation of the cytotoxicity of bioinspired coumarin analogues towards human breast cancer cells.生物灵感香豆素类似物对人乳腺癌细胞的细胞毒性研究。
Mol Divers. 2021 Feb;25(1):307-321. doi: 10.1007/s11030-020-10082-6. Epub 2020 Apr 23.
10
The Alpha Isoform of Heat Shock Protein 90 and the Co-chaperones p23 and Cdc37 Promote Opioid Anti-nociception in the Brain.热休克蛋白90的α亚型以及共伴侣蛋白p23和Cdc37促进大脑中的阿片类药物镇痛作用。
Front Mol Neurosci. 2019 Nov 29;12:294. doi: 10.3389/fnmol.2019.00294. eCollection 2019.
Curr Top Med Chem. 2009;9(15):1447-61. doi: 10.2174/156802609789895683.
4
KU135, a novel novobiocin-derived C-terminal inhibitor of the 90-kDa heat shock protein, exerts potent antiproliferative effects in human leukemic cells.KU135是一种新型的源自新生霉素的90 kDa热休克蛋白C端抑制剂，对人白血病细胞具有强大的抗增殖作用。
Mol Pharmacol. 2009 Dec;76(6):1314-22. doi: 10.1124/mol.109.058545. Epub 2009 Sep 9.
5
Natural product inhibitors of Hsp90: potential leads for drug discovery.热休克蛋白90（Hsp90）的天然产物抑制剂：药物研发的潜在先导物
Mini Rev Med Chem. 2009 Feb;9(2):140-52. doi: 10.2174/138955709787316056.
6
Novobiocin and additional inhibitors of the Hsp90 C-terminal nucleotide-binding pocket.新生霉素及Hsp90 C端核苷酸结合口袋的其他抑制剂。
Curr Med Chem. 2008;15(26):2702-17. doi: 10.2174/092986708786242895.
7
The design, synthesis, and evaluation of coumarin ring derivatives of the novobiocin scaffold that exhibit antiproliferative activity.对新霉素支架的香豆素环衍生物进行设计、合成及评估，这些衍生物具有抗增殖活性。
J Org Chem. 2008 Nov 21;73(22):8901-20. doi: 10.1021/jo801312r. Epub 2008 Oct 22.
8
Synthesis and biological activity of simplified denoviose-coumarins related to novobiocin as potent inhibitors of heat-shock protein 90 (hsp90).作为热休克蛋白90（hsp90）强效抑制剂的与新生霉素相关的简化去氧戊糖香豆素的合成及生物活性
Bioorg Med Chem Lett. 2008 Apr 1;18(7):2495-8. doi: 10.1016/j.bmcl.2008.01.128. Epub 2008 Feb 14.
9
Development of novobiocin analogues that manifest anti-proliferative activity against several cancer cell lines.表现出对多种癌细胞系具有抗增殖活性的新生霉素类似物的开发。
J Org Chem. 2008 Mar 21;73(6):2130-7. doi: 10.1021/jo702191a. Epub 2008 Feb 23.
10
Hsp90: a novel target for the disruption of multiple signaling cascades.热休克蛋白90：一种破坏多种信号级联反应的新型靶点。
Curr Cancer Drug Targets. 2007 Jun;7(4):369-88. doi: 10.2174/156800907780809778.